RxDoctor Payments Data

Stephen Ehiremen, MD

Obstetrics & Gynecology · Memphis, TNNPI 1699963249

Payments from drug & device makers

$671in general payments, 2019–2025

Across 29 payments — averaging $23.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$206
  • Biogen$163
  • Aspira Women's Health Inc$128
  • Shield Therapeutics Inc$47
  • Mylan Pharmaceuticals Inc.$43
  • Optumhealth Care Solutions, LLC$27
  • plus $57 from 3 others

What the payments were for

  • Food & beverage$671100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie12$206
Biogen6$163
Aspira Women's Health Inc1$128
Shield Therapeutics Inc3$47
Mylan Pharmaceuticals Inc.3$43
Optumhealth Care Solutions, LLC1$27
Organon1$26
Medtronic1$17
Lupin Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$671 in reported general payments places this provider in the 40th percentile of 763 obstetrics & gynecology providers in Tennessee.

See all obstetrics & gynecology providers in Tennessee

Medicare billing

Part B allowed, 2024
$4,093
Medicare patients
23
Services billed
42

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated24$7,459
Fluconazole46$250
ValacyclovirValacyclovir Hcl13$176
Metronidazole26$148
Naproxen11$64

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →